Transforming Precision NSCLC Care: Educating and Supporting Patients on HER2- and TROP2-Targeted ADCs

Gain a deeper understanding of HER2- and TROP2-targeted antibody–drug conjugates (ADCs) in NSCLC, including biomarker testing, mechanism of action for available ADCs, latest clinical data and guideline updates, and patient education on identification and management of ADC-related adverse events. Download the slides and read a clinical commentary from 2 nurse specialists involved in the management of patients with NSCLC.

Share

Program Content

Activities

Molecular Testing and Novel Indications for NSCLC
Fundamentals I: Integrating Molecular Testing and Novel Indications Into Clinical Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2024

Expires: May 10, 2025

Emerging Role of ADCs in NSCLC
Fundamentals II: Emerging Role of HER2- and TROP2-Targeted ADCs in NSCLC—What APPs Need to Know
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2024

Expires: May 11, 2025

Recognizing and Managing AEs in NSCLC
Fundamentals III: Recognizing and Managing AEs and Addressing Adherence and Barriers
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2024

Expires: May 11, 2025

Activities

TROP-2–Targeted ADCs
Transforming Precision NSCLC Care: Educating and Supporting Patients on TROP-2–Targeted ADCs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 09, 2024

Expires: October 08, 2025

HER2̶Targeted ADCs
Transforming Precision NSCLC Care: Educating and Supporting Patients on HER2-Targeted ADCs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 10, 2024

Expires: October 09, 2025

Activities

ADCs for Advanced NSCLC
The Use of Antibody–Drug Conjugates as Novel Therapies for Patients With Advanced NSCLC: Advanced Practice Professional Considerations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2024

Expires: September 26, 2025

Faculty

cover img faculity

Edward B. Garon, MD, MS

Professor
Director of Thoracic Oncology
David Geffen School of Medicine at UCLA
Co-Director of Signal Transduction and Therapeutics Program
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California

cover img faculity

Blanca Ledezma, MSN, NP-AOCNP

Nurse Practitioner III
Division of Hematology/Oncology
UCLA Santa Monica
Santa Monica, California

cover img faculity

Denise Rouse, MS, PA-C

Physician Assistant
Thoracic Medical Oncology
Department of Medicine, Section of Hematology/Oncology
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education, in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner